2018-12-21T13:43:12-06:00 2018-03-31 330310569 HASKELL & WHITE LLP 300 SPECTRUM CENTER DR STE 300 IRVINE CA 92618 990 2017-04-01 956043953 ARTHRITIS NATIONAL RESEARCH FOUNDATION ARTH 5624376808 5354 E SECOND STREET NO 201 LONG BEACH CA 90803 DEBBIE SAMPSON PRESIDENT OF THE BOARD 5624376808 2018-12-21 1 RICK SMETANKA P01677376 9494506200 216.73.111.4 2018-12-21 11:43:07 PS P 6D7510648C41C86CF617460AFBEAAF85574F14DA 2889FD29B07997755604846C7F8124F64E771304 2017 2019-02-21 02:37:17Z DEBBIE SAMPSON 5354 E 2ND ST STE 201 LONG BEACH CA 90803 4162915 0 X HTTP://WWW.CUREARTHRITIS.ORG X 1952 CA PROVIDE FINANCIAL SUPPORT FOR PREVENTION,TREATMENT & CURE OF ARTHRITIS & OTHER RHEUMATIC DISEASES. 15 13 5 50 0 0 829799 2540870 0 0 403302 399532 48045 23401 1281146 2963803 1120060 1313510 0 0 284034 435620 0 0 120016 265999 281635 1670093 2030765 -388947 933038 8267105 9586356 57616 44291 8209489 9542065 TO PROVIDE INITIAL RESEARCH FUNDING TO BRILLIANT, INVESTIGATIVE SCIENTISTS WITH NEW IDEAS TO CURE ARTHRITIS AND RELATED AUTOIMMUNE DISEASES 0 0 1537187 1313510 EACH YEAR, ARTHRITIS RESEARCH GRANTS ARE AWARDED TO INDEPENDENT MD AND/OR PHD SCIENTISTS AT UNAFFILIATED RESEARCH FACILITIES AND UNIVERSITIES ACROSS THE COUNTRY. ANRF'S SCIENTIFIC ADVISORY BOARD PERFORMS A NIH-LEVEL REVIEW OF ALL APPLICATIONS, RANKING THE PROPOSALS AS TO THE EXCELLENCE OF THE SCIENCE, OPPORTUNITY TO MAKE A BREAK-THROUGH DISCOVERY AND THE QUALITY OF THE INVESTIGATOR AWARDEES, WHO RECEIVE A MAXIMUM GRANT OF $100,000. APPLICANTS MUST PROVIDE PROGRESS AND FINAL REPORTS OF THEIR WORK, INCLUDING PUBLICATIONS IN SCIENTIFIC JOURNALS AND PRESENTATIONS AT SCIENTIFIC MEETINGS. IF PROGRESS IS DEEMED SIGNIFICANT IN THE FIRST YEAR, AWARDEES MAY APPLY FOR AND EARN A SECOND YEAR OF SUPPORT. ANRF ALSO SUPPORTS SMALL TRAVEL GRANTS TO SCIENTIFIC MEETINGS FOR YOUNG INVESTIGATORS. 236428 ANRF HAS VARIOUS PROGRAMS TO RAISE AWARENESS WITHIN THE GENERAL PUBLIC,THOSE SUFFERING WITH ARTHRITIS AND THE MEDICAL/SCIENTIFIC RESEARCH COMMUNITIES ABOUT THE IMPORTANCE OF AND NEED FOR ARTHRITIS RESEARCH FOR DEVELOPING A CURE AND MORE EFFECTIVE TREATMENTS. ALSO PART OF THE EDUCATION COMPONENT IS RAISING AWARENESS OF THE PREVALENCE OF ARTHRITIS, THE FACT THAT CHILDREN GET ARTHRITIS AND THE CURRENT WORK BEING DONE IN THE FIELD OF ARTHRITIS RESEARCH. 1773615 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 1 5 1 0 0 0 0 0 1 1 0 0 0 0 X 15 13 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA AZ CT IL VA FL WA NJ TX NC NY X X X ZAHER NAHLE 5624376808 5354 E SECOND STREET STE 201 LONG BEACH CA 90803 SHAUN SKERIS PRESIDENT (OUTGOING) 5.00 X X 0 0 0 SALLY ANNE SHERIDIAN VICE PRESIDENT 1.00 X X 0 0 0 KELLY ROUBA 2ND VICE PRESIDENT 1.00 X X 0 0 0 HELENE BELISLE EXECUTIVE DIR/SEC (OUTGOING) 40.00 X X 120000 0 15654 MARK SCHULTEN TREASURER 1.00 X X 0 0 0 KEVIN DONOHUE DIRECTOR 1.00 X 0 0 0 KATHRYN S FERRIS DIRECTOR 1.00 X 0 0 0 GALE A GRANGER PHD DIRECTOR 1.00 X 0 0 0 BRITT MEYER DIRECTOR 1.00 X 0 0 0 LYNN E MOYER DIRECTOR 1.00 X 0 0 0 SCHALON NEWTON DM DIRECTOR 1.00 X 0 0 0 DEBBIE SAMPSON PRESIDENT OF THE BOARD (INCOMING) 5.00 X X 0 0 0 CARL WARE PHD DIRECTOR 1.00 X 1400 0 0 DAVID ISRAELSKY DIRECTOR 1.00 X 0 0 0 MICHAEL LEBLANC DIRECTOR 1.00 X 0 0 0 ZAHER NAHLE EXECUTIVE DIRECTOR (INCOMING) 40.00 X X 0 0 0 JONATHAN ROSE DIRECTOR 1.00 X 0 0 0 CRAIG WALSH DIRECTOR 1.00 X 1600 0 0 123000 0 15654 1 0 0 0 0 139789 115094 2285987 2540870 161308 161308 1388128 1149904 238224 238224 238224 72609 115094 49208 23401 23401 2963803 238224 0 184709 1290411 1290411 23099 23099 162030 118280 15083 28667 75364 54985 7148 13231 143370 74765 26541 42064 26363 17606 3801 4956 28493 19233 3343 5917 21222 21222 35535 25475 10060 18977 15775 3202 80346 38813 31687 9846 16512 14032 2167 313 31615 16878 9387 5350 7915 1843 5535 537 AWARENESS PROGRAM 29607 29607 0 0 BOARD MEETINGS 18111 17955 74 82 PRINTING 14352 12483 675 1194 WORKPLACE CAMPAIGN 5432 800 50 4582 2011 1575 361 75 2030765 1773615 137134 120016 117 435343 341068 1098040 0 88265 56415 56415 7274169 7877610 548723 46613 30683 8267105 9586356 5106 44291 52510 0 57616 44291 X 7773099 9105675 426104 426104 10286 10286 8209489 9542065 8267105 9586356 933038 399538 0 X 0 1 X 1 0 X 990456 1009083 1134893 829799 2564271 6528502 990456 1009083 1134893 829799 2564271 6528502 1230495 5298007 165869 162005 156230 171807 161308 817219 7345721 0.72120 0.68270 X 4335168 0 460667 250000 4545835 3789441 69262 476465 4335168 4075723 606842 -92958 800166 3789441 4401092 101000 274069 700438 4075723 3993660 2556 405550 674 4401092 0.90400 0.00200 0.09400 0 0 0 X 3342119 399538 399538 2942581 21222 21222 2963803 2009543 0 2009543 21222 21222 2030765 PART V, LINE 4: AN ENDOWMENT ACCOUNT WAS ESTABLISHED IN FISCAL YEAR 2007-08. THE BOARD OF DIRECTORS CAN, AND HAS MADE THE DECISION TO ADD UNRESTRICTED FUNDS TO THE ENDOWMENT FUND IN ORDER TO GROW THIS FUND SO THAT FUTURE INCOME EARNED MAY BE USED FOR GRANT AWARDS AND ORGANIZATION OPERATIONS. IF NECESSARY, THE ENDOWMENT ACCOUNT IS MANAGED BY MEMBERS OF THE BOARD OF DIRECTORS' FINANCE COMMITTEE. PART X, LINE 2: THE FOUNDATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS ITS FILING STATUS AS TAX-EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITIES WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE FOUNDATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL PURPOSES IS THREE YEARS AND FOR CALIFORNIA PURPOSES IS FOUR YEARS. MEET THE SCIENTISTS 167621 97418 70203 44668 2134 AWARENESS PROGRAMS 20082 17676 2406 2406 187703 115094 72609 44668 2134 2406 49208 23401 1 UNIVERSITY OF ROCHESTER 500 JOSEPH C WILSON BLVD ROCHESTER NY 14627 160743209 501(C)(3) 100000 THERAPEUTIC TARGETING OF GPCR GBETAGAMMA-GRK2 SIGNALING IN OSTEOARTHRITIS. LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY 9420 ATHENA CIRCLE SAN DIEGO CA 92037 330328688 501(C)(3) 100000 ACTIVIN A REGULATION OF T FOLLICULAR HELPER CELL BIOLOGY IN RHEUMATOID ARTHRITIS. RUSH UNIVESITY MEDICAL CENTER 1700 W VAN BUREN ROOM 150 CHICAGO IL 60612 362174823 501(C)(3) 100000 IDENTIFYING NOVEL MECHANOTRANSDUCTION TARGETS FOR TREATING OSTEOARTHRITIS. UNIVERSITY OF CALIFORNIA BERKELEY 120 SPROUL HALL UNIVERSITY OF CALIFORNIA BERKELEY CA 94720 946002123 PUBLIC UNIVERSITY 90411 PREDICTING TISSUE GROWTH POTENTIAL USING HIGH-THROUGHPUT SCREENING FOR CELL MECHANICS. REGENTS OF THE UNIVERSITY OF MICHIGAN 500 S STATE ST ANN ARBOR MI 48109 386006309 PUBLIC UNIVERSITY 100000 THE ROLE OF MATRICELLULAR PROTEIN CYR61 IN FIBROSIS AND ANGIOGENESIS IN SCLERODERMA. BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 501(C)(3) 100000 VALIDATING STAT3 AS A THERAPEUTIC TARGET IN ARTHRITIS. NORTHWESTERN UNIVERSITY 333 CLARK ST EVANSTON IL 60208 362167817 501(C)(3) 100000 COMPARING THE REGULATORY NETWORKS UNDERLYING INFLAMMATION IN ARTHRITIS AND AGING. VAN ANDEL RESEARCH INSTITUTE 333 BOSTWICK AVE NE GRAND RAPIDS MI 49503 522000820 501(C)(3) 100000 THE FUNCTION OF SENP6 DESUMOYLASE IN PREVENTING ARTICULAR CHONDROCYTE SENESCENCE AND OSTEOARTHRITIS DEVELOPMENT. BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVE BOSTON MA 02115 042774441 501(C)(3) 100000 IDENTIFYING NOVEL DEVELOPMENTAL PROGENITORS OF ARTICULAR CARTILAGE. SEATTLE CHILDREN'S HOSPITAL 4800 SAND POINT WAY NE SEATTLE WA 98105 910564748 501(C)(3) 100000 MECHANISMS UNDERLYING TACI-DEPENDENT ACTIVATION OF IMMATURE TRANSITIONAL B CELLS IN BAFF-DRIVEN HUMORAL AUTOIMMUNITY. REGENTS OF THE UNIVERSITY OF MICHIGAN 500 S STATE ST ANN ARBOR MI 48109 386006309 PUBLIC UNIVERSITY 100000 THROMBO-INFLAMMATORY ROLE OF NEUTROPHILS IN LUPUS. UNIVERSITY OF ALABAMA AT BIRMINGHAM 1720 2ND AVE S BIRMINGHAM AL 35294 636005396 PUBLIC UNIVERSITY 100000 GENETIC AND EPIGENETIC DETERMINANTS OF GOUT. UNIVERSITY OF MICHIGAN 500 S STATE ST ANN ARBOR MI 48109 386006309 PUBLIC UNIVERSITY 50000 PERSONALIZED APPROACH TO ENHANCE PREDICTION OF PSORIATIC ARTHRITIS. UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 523 E FRANKLIN ST CHAPEL HILL NC 27514 561150509 PUBLIC UNIVERSITY 50000 CELLULAR SENESCENCE AS A DRIVER AND THERAPEUTIC TARGET FOR OSTEOARTHRITIS. 8 14 TRAVEL GRANTS FOR PROFESSIONAL MEETING SUPPORT 7 23099 PART I, LINE 2: THE SCIENTIFIC ADVISORY BOARD (SAB) OF THE ORGANIZATION REVIEWS THE GRANT APPLICATIONS AND RECOMMENDS TO THE BOARD OF DIRECTORS A LIST OF GRANTS THEY BELIEVE ARE WORTHY OF FUNDING. THE EXECUTIVE DIRECTOR AND STAFF OF THE ORGANIZATION REVIEW AND MONITOR THE GRANTS AWARDED. DEREK BELISLE FAMILY MEMBER OF HELENE BELISLE 75364 COMPENSATION PAID FOR SERVICES AS AN EMPLOYEE 0 FORM 990, PART VI, SECTION B, LINE 11B BOTH THE AUDITED FINANCIAL STATEMENTS AND FORM 990 ARE DISTRIBUTED TO THE MEMBERS OF THE BOARD FOR REVIEW. UPON APPROVAL BY THE BOARD OF DIRECTORS, THE EXECUTIVE DIRECTOR SIGNS AND RELEASES THESE DOCUMENTS TO THE PUBLIC, POSTS ON THE WEBSITE, AND/OR SUBMITS THE DOCUMENTS TO THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C CONFLICTS OF INTEREST ARE MONITORED CONSTANTLY THROUGH AN ANNUAL WRITTEN CONFIRMATION THAT IS COMPLETED AND SUBMITTED BY ALL BOARD MEMBERS. ADDITIONALLY, ANY POSSIBLE INDICATION OF CONFLICTS OF INTEREST THAT ARE BROUGHT TO THE ATTENTION OF THE BOARD, SAB MEMBERS OR THE EXECUTIVE DIRECTOR ARE FURTHER REVIEWED BY THE AUDIT COMMITTEE CHAIR TO DETERMINE WHETHER OR NOT A CONFLICT OF INTEREST EXISTS. ANRF IS VIGILANT IN ITS POLICIES WITH REGARDS TO CONFLICT OF INTEREST. AFTER REVIEW BY THE AUDIT COMMITTEE CHAIR, IF THERE ARE REMAINING QUESTIONS AS TO A CONFLICT OF INTEREST, ANRF'S COUNSEL WOULD BE CONTACTED AND THE MATTER BROUGHT UP TO ALL INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS THAT WOULD MAKE THE FINAL DETERMINATION AS TO WHETHER OR NOT A CONFLICT EXISTS. FORM 990, PART VI, SECTION B, LINE 15 THE FINANCE COMMITTEE WORKED WITH AN ADVISORY BOARD MEMBER WHO IS AN EXPERT IN HUMAN RESOURCES. FOR THE PURPOSES OF DETERMINING COMPENSATION OF THE EXECUTIVE DIRECTOR, TOGETHER THEY FORMED A COMPENSATION COMMITTEE. THIS INCLUDED REVIEW OF COMPARABLE COMPENSATION FOR COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS AND AN ONLINE SALARY REVIEW COMPLETED BY EVERY BOARD AND ADVISORY BOARD MEMBER, TALLIED BY COMPENSATION COMMITTEE. THIS PROCESS WAS FOLLOWED FOR FISCAL YEAR 2014-15, 2015-16 AND 2016-17. FORM 990, PART VI, SECTION C, LINE 19 ALL REQUESTS FOR THE 990, FORM 1023, FINANCIAL STATEMENTS AND ORGANIZATIONAL DOCUMENTS SUCH AS OUR CONFLICT OF INTEREST POLICY, AND GOVERNING DOCUMENTS WILL BE SENT OUT BY REQUEST VIA REGULAR MAIL OR E-MAIL. THE 990'S ARE ALL POSTED ON OUR WEBSITE.